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Summary
Introduction:  Rhabdomyosarcoma  (RMS)  is  a  rare  sarcoma,  in  which  paranasal  sinus  locations
are exceptional  in  adults.
Case  report:  We  report  a  case  of  ethmoid  metastatic  RMS  in  a  48-year-old  patient,  discovered
in connection  with  recurrent  epistaxis  associated  with  exophthalmia  and  ophthalmoplegia.  The
tumor was  inoperable  and  chemotherapy  based  on  adriamycin  was  initiated.  The  course  was,
however,  marked  by  rapid  worsening  of  symptoms  and  the  patient’s  death.
Discussion:  Paranasal  sinus  RMS  shows  no  speciﬁc  clinical  signs,  and  diagnosis  is  mainly  based
on immunohistochemical  analysis.  The  association  of  surgery  and  chemo-radiotherapy  is  the
optimal attitude,  but  surgical  resection  is  often  impossible  due  to  local  extension.  Prognosis  in
adults is  poor.
©  2012  Elsevier  Masson  SAS.  All  rights  reserved.
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introduction
habdomyosarcoma  (RMS)  is  a  tumor  of  the  conjunctive
issue,  found  more  frequently  and  with  better  prognosis
n  children  than  adults.  ENT  forms  are  not  unusual,  but
aranasal  sinus  locations  are  exceptional.  We  report  a  case
f  adult  evolved  ethmoid  RMS,  and  discuss  the  characteris-
ics,  diagnosis  and  treatment  of  such  tumors.∗ Corresponding author.
E-mail address: aubryorl@aol.com (K. Aubry).
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 48-year-old  man  was  referred  to  ENT  for  recurrent  epis-
axis.  Brain  and  facial  sinus  CT  found  30  ×  25  mm  tissular
lling  of  the  left  anterior  and  medial  ethmoid  cells,  with
thmoid  and  papyraceous  lamina  bone  lysis  without  intra-
rbital  extension.  Biological  assessment  found  anemia  and
hrombopenia.  A  myelogram  was  therefore  taken,  which
ndicated  massive  metastatic  medullary  invasion.  Biopsies,
nder  general  anesthesia,  proved  highly  hemorrhagic.  Sub-
equent  recurrent  epistaxis  required  platelet  transfusion
very  two  days;  very  rapid  onset  of  left  exophthalmia
as  associated  with  ptosis,  superior  palpebral  edema
nd  ophthalmoplegia.  Contrast-enhanced  cervico-thoraco-
bdomino-pelvic  CT  showed  no  secondary  pulmonary  or
epatic  locations.  MRI  found  tumoral  extension  toward
he  frontal  sinus,  frontal  cortex  and  left  intra-orbital
served.
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DFigure  1  Brain  MRI  (horizontal  T1-weighted  gadolinium-enhan
extension,  exerting  a  mass  effect  on  the  right  medial  rectus  mu
region  (Fig.  1).  18-ﬂuoro-desoxy-glucose  positron  emis-
sion  tomography  (18FDG-PET)  found  hypermetabolic  cervical
lymph-node  sites  and  diffuse  osteo-medullary  inﬁltration
(Fig.  2).  Deﬁnitive  anatomopathologic  examination  diag-
nosed  grade-3  alveolar  RMS  on  the  Fédération  Nationale  des
Centres  de  Lutte  Contre  le  Cancer  (FNCLCC)  classiﬁcation.
Immunohistochemistry  was  positive  for  anti-desmin,  anti-
NCAM  (neural  cell  adhesion  molecule)  and  anti-myogenin
antibodies,  and  negative  for  anti-caldesmon  antibodies
(Fig.  3).  Fluorescence  in  situ  hybridization  (FISH)  analy-
sis  found  FKHR  gene  rearrangement.  A  multidisciplinary
team  meeting  decided,  given  the  tumoral  extension,  on  ini-
tial  adriamycin-based  chemotherapy  associated  to  regular
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Figure  2 18FDG-PET.  A.  Horizontal,  sagittal  and  frontal  slices  in  C
lesion with  bone  lysis  areas.  B.  Scintigraphic  images,  showing  diffuse
right: non-corrected  attenuation  MIP.lices).  A.  Left  ethmoid  tumoral  syndrome  with  left  intra-orbital
.  B.  Left  frontal  lobe  tumoral  invasion.
ransfusion  and  neutrophil  growth  factor  injection.  After
nitial  improvement  in  general  health  status  and  disap-
earance  of  the  epistaxis,  there  was  rapid  deterioration  of
onsciousness,  due  to  onset  of  left  frontal  intraparenchy-
atous  cerebral  hematoma;  the  patient  died  5  weeks  after
nitiation  of  chemotherapy.
iscussionMS  is  a  rare  malignant  tumor,  originating  in  the  conjunc-
ive  and  derivative  tissue.  It  is  especially  rare  in  adults,
hereas  it  is  the  most  frequent  form  of  soft-tissue  tumor
T  paired  to  scintigraphy,  showing  inﬁltration  via  the  skull-base
 osteo-medullary  inﬁltration.  Left:  corrected  attenuation  MIP;
28  A.  El  Sanharawi  et  al.
Figure  3  Anatomopathologic  examination  of  sinus  RMS.  A.  Chorion  inﬁltration  by  loosely  arranged  round-cell  proliferation  (HES,
enlargement × 10).  B.  Numerous  intra-tumoral  cytonuclear  abnormalities  and  mitoses  (HES,  enlargement  ×  40).  C.  Dense  eosinophil
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Wspect of  the  cytoplasm  of  certain  tumor  cells  (arrows),  suggest
umor-cell anti-myogenin  antibody  immunomarking  (enlargeme
n  children  [1].  Histologically,  three  types  are  distinguished:
mbryonic,  alveolar  and  pleomorphic.  The  embryonic  type  is
he  one  most  frequently  encountered  in  ENT,  mainly  affect-
ng  children  under  5  years  of  age;  it  is  found  in  25%  of
asopharynx  and  sinonasal  cavity  RMS  locations,  and  is  the
orm  associated  with  the  best  prognosis.  The  alveolar  type
ainly  affects  children  over  5  years  of  age,  adolescents
nd  young  adults;  it  may  be  located  in  the  sinonasal  cav-
ties,  and  is  of  poorer  prognosis.  The  pleomorphic  form
s  rarer,  mainly  affects  adults  and  is  of  poor  prognosis
1].
RMS  mainly  develops  in  the  thorax  or  extremities  in
dults,  and  in  the  ENT  region  or  uro-genital  tract  in  children
2].  Only  10—15%  of  adult  ENT  locations  are  in  the  paranasal
inuses  [3,4].
At  the  outset  of  management,  RMS  does  not  present
ny  speciﬁc  clinical  signs  (except  for  the  embryonic  form,
hich  may  have  the  aspect  of  a  gelatinous  nasal  polyp)
1,2].  Sinus  involvement  presents  as  early  epistaxis  asso-
iated  with  exophthalmia  and  ophthalmoplegia.  Imaging
oes  not  determine  diagnosis,  but  does  assess  locoregional
xtension.  On  MRI,  the  tumor  shows  a  heterogeneous  sig-
al,  equal  to  or  more  intense  than  the  muscle  [5].  Only
istology  with  immunohistochemistry  provides  speciﬁc  diag-
osis,  in  the  form  of  diffuse  desmin  and  myogenin  staining.
enetically,  t(2;13)(q35;q14)  or  t(1;13)(q36;q14)  transloca-
ion  is  speciﬁc,  and  is  found  in  all  alveolar  forms,  indicating
earrangement  of  the  FKHR  gene  into  either  PAX3-FKHR  or
AX7-FKHR  gene  [1].
C
P
af  rhabdoid  differentiation  (HES,  enlargement  × 63).  D.  Nuclear
20).
RMS shows  very  rapid  spontaneous  evolution;  diagnosis
s  very  often  at  an  advanced  stage  [3].  Prognosis  is  poor,
ith  frequent  lymph-node,  lung  or  bone  metastasis  [1,6].
xtension  assessment  should  include  myelogram,  brain  and
inus  MRI,  contrast-enhanced  cervico-thoraco-abdominal  CT
nd 18FDG-PET.
Prognosis  is  poorer  in  adults  than  children,  and  ENT
ocations  are  usually  difﬁcult  to  resect  due  to  extension.
enetic  analysis  provides  complementary  prognostic  infor-
ation,  t(1;13)(q36;q14)  translocation  being  associated
ith  a  poorer  prognosis  than  t(2;13)(q35;q14)  translocation
n  alveolar  forms  [1].
Treatment  ideally  associates  surgery  and  radio-
hemotherapy.  Surgery  should  be  the  ﬁrst-line  attitude
n  operable  ENT  forms.  Adjuvant  radiation  therapy  may,
epending  on  team  experience,  help  optimize  control
7].  Chemotherapy  classically  associates  vincristine-
actinomycin-cyclophosphamide,  with  adriamycin
onotherapy  reserved  for  advanced  forms  [8].  Non-
perable  forms  should  be  managed  by  neo-adjuvant
hemotherapy  then,  depending  on  regression  and  general
ealth  status,  surgery  followed  by  radio-chemotherapy.
hatever  the  treatment,  prognosis  in  adults  is  poor  [6].onclusion
aranasal  sinus  RMS  is  a  rare  tumor  of  poor  prognosis  in
dults.  Locoregional  extension  is  frequently  advanced  at
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[Paranasal  sinus  rhabdomyosarcoma:  A  rare  tumor  of  poor  pr
diagnosis,  limiting  treatment  options  and  worsening  progno-
sis.  Surgery  followed  by  radio-chemotherapy  is  the  attitude
of  choice  in  locally  advanced  and  metastatic  forms.
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